Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer.

Sinha A, Pandya DN, Eeka P, Boyacioglu O, Gmeiner WH, Wadas TJ

Open source

DOI
10.3390/molecules31030493
Published
2026 Jan 31
Container
Molecules (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/molecules31030493,
  title = {Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer.},
  author = {Sinha A and Pandya DN and Eeka P and Boyacioglu O and Gmeiner WH and Wadas TJ},
  year = {2026},
  journal = {Molecules (Basel, Switzerland)},
  doi = {10.3390/molecules31030493},
  url = {https://doi.org/10.3390/molecules31030493}
}

RIS

TY  - JOUR
TI  - Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer.
AU  - Sinha A
AU  - Pandya DN
AU  - Eeka P
AU  - Boyacioglu O
AU  - Gmeiner WH
AU  - Wadas TJ
PY  - 2026
JO  - Molecules (Basel, Switzerland)
DO  - 10.3390/molecules31030493
UR  - https://doi.org/10.3390/molecules31030493
ER  - 

APA

A, S., DN, P., P, E., O, B., WH, G., & TJ, W. (2026). Preclinical Evaluation of a Radiolabeled Anti-PSMA Dimeric Aptamer in a Murine Model of Human Prostate Cancer.. Molecules (Basel, Switzerland). https://doi.org/10.3390/molecules31030493

Source records